A phase 1 study of MVT-602 in healthy women volunteers
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2018
Price : $35 *
At a glance
- Drugs MVT 602 (Primary)
- Indications Female infertility
- Focus Adverse reactions
- 10 Oct 2018 According to a Myovant Sciences media release, results from this study were presented at the 2018 American Society for Reproductive Medicine (ASRM) Annual Congress.
- 10 Oct 2018 Results presented in a Myovant Sciences media release.
- 13 Jun 2018 New trial record